- Home
- BBIO vs CHX Comparison
BBIO vs CHX Comparison
Compare BBIO & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- CHX
- Stock Information
- Founded
- BBIO 2015
- CHX 1882
- Country
- BBIO United States
- CHX United States
- Employees
- BBIO N/A
- CHX N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- CHX Industrial Machinery/Components
- Sector
- BBIO Health Care
- CHX Industrials
- Exchange
- BBIO Nasdaq
- CHX Nasdaq
- Market Cap
- BBIO 5.6B
- CHX 5.5B
- IPO Year
- BBIO 2019
- CHX N/A
- Fundamental
- Price
- BBIO $36.08
- CHX $31.27
- Analyst Decision
- BBIO Strong Buy
- CHX Buy
- Analyst Count
- BBIO 13
- CHX 3
- Target Price
- BBIO $48.33
- CHX $41.33
- AVG Volume (30 Days)
- BBIO 2.5M
- CHX 2.2M
- Earning Date
- BBIO 02-20-2025
- CHX 02-03-2025
- Dividend Yield
- BBIO N/A
- CHX 1.22%
- EPS Growth
- BBIO N/A
- CHX 7.15
- EPS
- BBIO N/A
- CHX 1.62
- Revenue
- BBIO $217,765,000.00
- CHX $3,665,501,000.00
- Revenue This Year
- BBIO $2,309.33
- CHX N/A
- Revenue Next Year
- BBIO N/A
- CHX $3.96
- P/E Ratio
- BBIO N/A
- CHX $19.16
- Revenue Growth
- BBIO 2209.77
- CHX N/A
- 52 Week Low
- BBIO $21.62
- CHX $25.57
- 52 Week High
- BBIO $41.04
- CHX $39.95
- Technical
- Relative Strength Index (RSI)
- BBIO 73.73
- CHX 73.98
- Support Level
- BBIO $33.73
- CHX $27.00
- Resistance Level
- BBIO $36.24
- CHX $28.13
- Average True Range (ATR)
- BBIO 1.63
- CHX 0.86
- MACD
- BBIO 0.65
- CHX 0.55
- Stochastic Oscillator
- BBIO 97.63
- CHX 87.63
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.